Experience of Using Therapeutic Drug Monitoring to Control the Safety of Vancomycin in Intensive Care Unit Patients with Sepsis

Experience of Using Therapeutic Drug Monitoring to Control the Safety of Vancomycin in Intensive Care Unit Patients with Sepsis

Vancomycin is prescribed to patients in serious condition with infections caused by Gram-positive microorganisms; however, if the therapeutic plasma concentration of the medicinal product is exceeded, it can have a nephrotoxic effect.The aim of the study was to demonstrate the possibility of using t...

Full description

Bibliographic Details
Main Authors: A. B. Prokofiev, S. A. Belkov, R. E. Kazakov, N. G. Berdnikova, T. A. Rodina, E. S. Melnikov, A. A. Danko, N. E. Voronova, R. Z. Vafina, A. V. Zavtoniev, D. V. Tsyganko, E. Yu. Demchenkova
Format: Article
Language:Russian
Published: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2022-07-01
Series:Безопасность и риск фармакотерапии
Subjects:
vancomycin
clinical case
toxic nephropathy
sepsis
therapeutic drug monitoring
Online Access:https://www.risksafety.ru/jour/article/view/251

Internet

https://www.risksafety.ru/jour/article/view/251

Similar Items